Clinical Trial Update: A 28 - 90 Days Study to Evaluate the Safety, Tolerability, and Efficacy of Caspofungin Injection as Empirical Therapy in Indian Adults With Persistent Fever and Neutropenia (0991-053)(COMPLETED) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating caspofungin as empirical therapy for fungal infection in Indian adults with persistent fever and neutropenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fungal Infection

Drugs mentioned

• Caspofungin (caspofungin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Fungal Infection | Phase 3 | Status: COMPLETED